Immunologic & Transplant Drugs PNLE Questions
Introduction
The live Tangerine inventory contains exactly 8 published practice questions for Immunologic & Transplant Drugs. It was last updated August 12, 2026. Treat this set as a focused diagnostic starting point, not as a forecast of any exam form.
This canonical scope trains you to connect a drug’s purpose with the patient’s immune status, transplant context, monitoring needs, and safety priorities. You practice recognizing why immunosuppression is continued, identifying important adverse-effect cues, distinguishing a medication concern from an expected treatment goal, and choosing the safest nursing response when infection, toxicity, or adherence is a concern. Allergy symptom relief belongs in Respiratory & Allergy Drugs, while anti-infectives belong in Anti-infectives.
NP7: Pharmacology is a Tangerine cross-cutting practice area, not a separate official PNLE test subject. Under the 2025 Enhanced TOS, these questions are mapped across relevant competencies within the official five-subject PNLE structure. The TOS provides broad competency weights; it does not assign a guaranteed number of questions to this microtopic, so exact distribution varies by exam form.
Key concepts
- Link the indication to the immune goal
Recognize: Immunosuppressants and biologics may reduce harmful immune activity in an autoimmune condition, while transplant regimens reduce the risk that the recipient’s immune system will injure the graft.
Decide: Identify the indication before judging whether the medication is appropriate or what teaching is needed.
Avoid: Choosing an answer from the drug name alone or treating every immune-related medication as interchangeable. - Protect continuity of transplant therapy
Recognize: A transplant recipient may need immunosuppression as an ongoing part of graft protection, even when the patient feels well.
Decide: Reinforce taking therapy exactly as prescribed and contacting the transplant team before a dose is missed, changed, or stopped.
Avoid: Presenting symptom-free status as permission to discontinue treatment. - Recognize calcineurin-inhibitor toxicity cues
Recognize: Cyclosporine and tacrolimus can be associated with kidney injury; reduced urine output, rising renal markers, blood pressure changes, or new tremor require attention.
Decide: Review ordered renal monitoring, blood pressure, medication timing, and drug levels when applicable, then report concerning findings.
Avoid: Independently changing the dose from one abnormal result or dismissing a finding because the medication was prescribed. - Handle corticosteroid effects safely
Recognize: Steroids can contribute to hyperglycemia, fluid retention, mood or sleep changes, infection risk, and impaired healing.
Decide: Monitor the relevant findings, provide ordered supportive care, and follow the prescribed taper or continuation plan.
Avoid: Abruptly stopping a steroid or labeling every expected effect as a reason for self-discontinuation. - Make biologic administration a safety assessment
Recognize: Biologics modify immune activity and may present concerns involving infection or an acute administration reaction.
Decide: Check the order and required precautions, observe the patient during administration as directed, and respond promptly to breathing difficulty, hypotension, or widespread rash.
Avoid: Focusing only on the intended immune target while overlooking immediate reaction cues. - Use monitoring and interaction information together
Recognize: Exposure to some immunosuppressants can change with other medicines, supplements, or inconsistent administration, making medication reconciliation important.
Decide: Ask about all prescribed, over-the-counter, and herbal products and reinforce the ordered monitoring plan.
Avoid: Assuming a nonprescription or herbal product is safe because it is not labeled a prescription drug. - Separate graft dysfunction from its possible causes
Recognize: New graft-related changes may reflect rejection, medication toxicity, infection, or another clinical problem; symptoms alone do not establish the diagnosis.
Decide: Assess the patient, review the available findings, and promptly communicate concerns through the transplant or prescribing team.
Avoid: Increasing immunosuppression independently or declaring rejection without assessment and appropriate evaluation.
What to expect on the PNLE
The 8 published questions support practice with medication-purpose, duration-of-therapy, adverse-effect, and priority-action forms. The live set is 4 easy, 3 medium, and 1 hard, with 5 remembering, 2 applying, and 1 evaluating. Retrieval is therefore the dominant cognitive demand in this inventory, while the applying items connect patient cues to an action and the evaluating item requires weighing competing safety explanations.
Practice prompts may present an immunosuppressant or biologic and ask why it is used, which finding requires attention, or what teaching best protects the patient. A scenario may require distinguishing possible medication toxicity from a transplant complication and choosing whether to assess, report, or reinforce the prescribed plan. Keep the indication, timing, symptoms, and monitoring data together before selecting an answer.
- Remembering: Retrieve drug purpose, treatment duration principles, major adverse effects, and monitoring targets.
- Applying: Connect a patient finding or medication situation with the safest nursing response.
- Evaluating: Weigh competing explanations such as toxicity, infection, and graft-related complications before deciding what requires escalation.
These categories describe the supplied Tangerine inventory, not a guarantee about any future form. The 2025 Enhanced TOS maps broad competencies across the official five PNLE subjects, and exact topic distribution varies by exam form.
Study tips
- Start with diagnostic practice. Complete all 8 published items without looking up answers first. Mark each response as certain, uncertain, or guessed, then identify whether the difficulty came from the indication, adverse effect, monitoring cue, or nursing action.
- Use focused retrieval. Build cards for immunosuppressants, biologics, corticosteroids, and transplant therapy. On the front, write the condition or context; on the back, write the immune purpose, priority danger cue, and safest nursing response.
- Make a comparison grid on paper.Context | Purpose | Cue to monitor | First response
Autoimmune flare | Control harmful immune activity | Treatment response and toxicity | Assess and follow the plan
Transplant regimen | Protect the graft | Adherence and organ function | Communicate concerns promptly
Biologic administration | Target immune activity | Acute reaction signs | Follow administration protocol - Review rationales and errors. For every wrong or guessed answer, write the decisive cue, the safety principle, and why the other options were less appropriate. Keep errors involving allergy relief or anti-infectives in their correct adjacent topic folders.
- Retry with spacing, then mix. Reanswer missed items later the same day, at the next study session, and after several days. Finish with mixed, timed practice that combines this topic with Anti-infectives, Respiratory & Allergy Drugs, and Oncology Drugs.
Common mistakes to avoid
- Confusing immune modulation with symptom relief or antimicrobial treatment.
Classify the medication by its indication and therapeutic purpose. If the stem centers on allergy symptoms, use the Respiratory & Allergy Drugs lens; if it centers on treating an infection, use Anti-infectives rather than forcing an immunologic-drug answer. - Stopping a transplant medication because the patient feels well.
The safety cue is the continuing need to protect the graft. Reinforce prescribed continuity and referral to the transplant team for missed doses, adverse effects, or requested changes. - Calling every new post-transplant problem rejection.
Reduced organ function or new symptoms can have several causes, including toxicity, infection, or another complication. Assess the available data and report promptly instead of making a diagnosis or increasing therapy independently. - Ignoring objective monitoring because the prescription is authorized.
Renal findings, blood pressure changes, glucose elevation, and other relevant data can signal medication harm. Use the ordered monitoring plan and connect the result with the drug’s known safety concern. - Continuing through a possible biologic reaction.
Breathing difficulty, hypotension, or a widespread rash requires immediate safety assessment and response according to protocol. Do not let the medication’s intended immune effect distract from an acute administration emergency. - Treating steroid adverse effects as a reason for abrupt withdrawal.
Recognize the adverse effect, assess severity, and follow the prescribed taper or continuation instructions. The medication plan must be changed by the responsible prescriber, not by the patient or nurse acting independently.
Try a question
A real Immunologic & Transplant Drugs question from our bank. Give it a shot.
A stable kidney transplant recipient wants to stop immunosuppressants because of tremor. What should the nurse advise?
Kidney transplant recipients require ongoing immunosuppressive therapy to prevent organ rejection. Stopping or adjusting immunosuppressant medications independently can result in acute rejection, graft loss, or life-threatening complications. It is crucial that any changes in therapy are overseen by the transplant team, who have the expertise to balance side effects with the critical need for immunosuppression.
B is correct because instructing the patient to contact the transplant team ensures a safe, coordinated approach. The transplant team can investigate the tremor’s cause, which might be a side effect of the medication (such as tacrolimus or cyclosporine) or due to another issue. They can assess severity, consider alternative agents, adjust doses, or add symptomatic management, all while vigilantly monitoring for signs of rejection. This respects patient safety, promotes optimal outcomes, and aligns with evidence-based practice and standards of nursing care.
| Option | Why This Choice Is Incorrect |
|---|---|
| A | Taking the medication at bedtime might make the tremor less noticeable, but it does not address the underlying issue of side effects or the risk to graft function. It may also disrupt medication schedules important for maintaining stable blood levels. Changing administration times should always be guided by the provider. |
| C | Pharmacists are valuable resources for medication information, but the management of immunosuppressant-related side effects, especially tremors in a transplant patient, requires direct medical oversight. Over-the-counter remedies could interact with immunosuppressants or delay necessary adjustments. Bypassing the transplant team increases risk. |
| D | Adjusting the dose independently is unsafe and outside nursing and patient role scopes. Immunosuppressant dosing is highly specialized, with narrow therapeutic ranges; unmonitored changes can lead to rejection or toxicity. Self-monitoring for rejection without clinical support is inappropriate. |
Clinical pearls:
- Never advise transplant patients to stop, skip, or adjust immunosuppression without provider guidance.
- Tremors are known adverse effects of calcineurin inhibitors. The transplant team can consider alternative agents or dose adjustments based on clinical status.
- Patient education focuses on recognizing side effects early and reporting promptly, not discontinuing medications.
This scenario tests the nurse’s clinical reasoning in pharmacologic safety, therapeutic communication, and appropriate escalation of care. Safe medication management in transplant recipients is a core component of nursing standards.
KDIGO. (n.d.). Guideline for care of kidney transplant recipients. https://kdigo.org/guidelines/transplant-recipient/
Hinkle, Janice L., Cheever, Kerry H., & Overbaugh, Kristen J. (2022). Brunner & Suddarth's Textbook of Medical-Surgical Nursing (15th ed.). Wolters Kluwer. https://shop.lww.com/Brunner---Suddarth-s-Textbook-of-Medical-Surgical-Nursing/p/9781975161033
More Immunologic & Transplant Drugs questions
8 questions available. Sign up to practice all of them.
A patient with a severe flare-up of Systemic Lupus Erythematosus is being treated in the hospital. Which medication is most likely to be included in the treatment plan?
A nurse is monitoring a post-kidney transplant patient who is receiving steroids. Which adverse effect should the nurse anticipate?
A client asks how long he will need to take immunosuppressive medications after a kidney transplant. What is the nurse’s best response?
References and further reading
- PRC Enhanced Table of Specifications for the Nurses Licensure Examination official
The current public competency and cognitive-level blueprint, effective from the November 2025 NLE onward. - Tangerine Prep PNLE Reviewer question bank
The live source for the published question count, question previews, rationales, and inventory distributions on this page.
How this page is built
The counts and distributions on this page come from Tangerine Prep's live published question bank. The source inventory was last updated on August 12, 2026.
The questions are original PNLE-style practice items, not recalled or leaked board questions. Topic scope follows Tangerine's pedagogical taxonomy and is mapped to the PRC 2025 Enhanced Table of Specifications, effective from the November 2025 NLE onward. Exact topic distribution varies by exam form.